V. Fleming

发表

Virological footprint of CD 4 + T-cell responses during chronic hepatitis C virus infection

P. Klenerman, E. Barnes, G. Harcourt, 2010 .

Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection

P. Klenerman, E. Barnes, G. Harcourt, 2010, The Journal of general virology.

CD161-Expressing Human T Cells

P. Klenerman, V. Fleming, J. Fergusson, 2011, Front. Immun..

Leukotriene E4 Activates Human Th2 Cells for Exaggerated Proinflammatory Cytokine Production in Response to Prostaglandin D2

P. Klenerman, G. Ogg, L. Xue, 2012, The Journal of Immunology.

CD161+CD4+ T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ

P. Klenerman, D. Adams, C. Willberg, 2012, Front. Immun..

Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution

Todd M. Allen, P. Klenerman, G. Lauer, 2009, Journal of Virology.

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men

Joseph Eliahoo, Emma C Thomson, P. Klenerman, 2010, Gut.

CD161 Defines a Transcriptional and Functional Phenotype across Distinct Human T Cell Lineages

Mark M. Davis, P. Klenerman, G. Freeman, 2014, Cell reports.

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells.

P. Klenerman, G. Lauer, D. Adams, 2012, Blood.

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties

J. Flint, P. Klenerman, D. Adams, 2010, Proceedings of the National Academy of Sciences.

TOBACCO CARCINOGEN-INDUCED 3~14.2 ALTERATIONS IN EXFOLIATED CELLS COLLECTED FROM THE ORAL CAVITY OF SMOKERS

V. Fleming, 2005 .

Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus.

B. Walker, P. Klenerman, G. Lauer, 2008, The Journal of clinical investigation.

Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

P. Klenerman, Jennifer A. Smith, A. McLean, 2010, The Journal of infectious diseases.

What Are the Prospects for Controlling Hepatitis C?

P. Klenerman, E. Barnes, V. Fleming, 2009, PLoS medicine.

Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection

O. Pybus, P. Klenerman, E. Barnes, 2009, Journal of Virology.

Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.

P. Fabris, V. Fleming, E. Barnes, 2008, Current pharmaceutical design.

Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection

O. Pybus, P. Klenerman, E. Barnes, 2010, Journal of Virology.